The Diagnosis You Haven't Received Yet
Insulin resistance is estimated to affect 40% of American adults. The majority have no idea.
That's not a small number. That's nearly half the country running a metabolic process that is actively generating fatigue, weight gain, hormonal disruption, cardiovascular risk, and cognitive fog — with no diagnosis, no treatment, and often no conversation.
Because standard medicine doesn't intervene until you cross the line into prediabetes or type 2 diabetes. By that point, insulin resistance has typically been present for a decade or more.
What Insulin Resistance Actually Is
Insulin's job is to shuttle glucose from the bloodstream into cells — muscle, liver, fat tissue — where it's used for energy or stored. When cells become less responsive to insulin's signal, the pancreas compensates by producing more of it.
For a while, this works. Blood glucose stays normal because the pancreas is working overtime. Fasting glucose looks fine. HbA1c looks fine. Insulin, however, is chronically elevated — and that elevation has systemic consequences that have nothing to do with blood sugar.
Hyperinsulemia — chronically elevated insulin — drives:
- Fat storage, particularly visceral and abdominal fat
- Suppression of fat burning (insulin is anti-lipolytic)
- Increased androgen production in women (driving PCOS and hormonal imbalance)
- Decreased testosterone in men
- Inflammation
- Accelerated cellular aging
- Impaired thyroid hormone conversion
- Disrupted sleep architecture
This is why patients with insulin resistance often present with a constellation of symptoms that seem unrelated — because the underlying driver is systemic, not localized to any one organ.
The Diagnostic Gap
A standard metabolic panel includes fasting glucose. That's it.
Fasting glucose remains normal in insulin-resistant patients until the pancreas can no longer compensate — which can take years to decades. By then, you're being diagnosed with prediabetes or type 2 diabetes after a long period in which you could have been helped significantly earlier.
Fasting insulin changes first. And most doctors don't order it.
A HOMA-IR score — calculated from fasting glucose and fasting insulin — is the clearest early marker of insulin resistance available without a glucose tolerance test. It doesn't require the patient to be diabetic. It doesn't require a formal metabolic diagnosis. It just requires ordering the right test.
We order it routinely.
What Insulin Resistance Feels Like
The symptom picture is often what brings patients in:
Fatigue after meals — particularly carbohydrate-heavy ones. Cells aren't efficiently using glucose, so energy production is impaired and blood sugar fluctuates.
Stubborn abdominal fat — the visceral depot is both a consequence and a driver of insulin resistance, creating a cycle that doesn't respond to caloric restriction alone.
Brain fog — the brain is exquisitely sensitive to glucose regulation. Dysglycemia produces cognitive cloudiness, particularly in the afternoon.
Strong carbohydrate cravings — cells are glucose-starved despite adequate blood sugar, creating persistent hunger that defies caloric logic.
Disrupted sleep — blood glucose fluctuations overnight drive cortisol release, fragmenting sleep architecture.
Hormonal dysregulation — in women, elevated insulin drives ovarian androgen production. In men, insulin resistance is independently associated with low testosterone.
Reversing It Without Medication
Insulin resistance is one of the most modifiable conditions in medicine. The levers that work:
Resistance training is the single most powerful tool. Muscle tissue is the primary glucose disposal organ. Building and maintaining muscle mass improves insulin sensitivity independently of any dietary change. Three to four sessions per week of compound, load-bearing exercise moves the needle significantly.
Reducing refined carbohydrate load — specifically processed carbohydrates and added sugars that produce rapid glucose and insulin spikes. This isn't about eliminating carbohydrates. It's about quality and timing.
Sleep optimization — a single night of 5–6 hours of sleep produces measurable insulin resistance the following day. Chronic sleep disruption compounds over time.
Stress load reduction — cortisol directly antagonizes insulin. Chronic stress chronically elevates cortisol. The HPA-metabolic axis is real and often ignored in insulin resistance management.
Time-restricted eating — extending the overnight fasting window (16–18 hours) reliably improves insulin sensitivity through multiple mechanisms. This isn't about starvation. It's about giving the metabolic system recovery time.
When Medication Is Appropriate
Metformin remains one of the most useful and well-studied medications in medicine — not just for diabetics, but for insulin-resistant patients who haven't responded sufficiently to lifestyle correction. Its mechanism is different from GLP-1s; it primarily reduces hepatic glucose output and improves insulin sensitivity directly.
For patients with established metabolic syndrome, combination approaches are often appropriate.
The goal in all cases is the same: restore metabolic flexibility. The ability to burn both glucose and fat efficiently, without the hyperinsulinemia driving everything downstream.
The Bottom Line
If you're tired, carrying weight you can't seem to shift despite reasonable effort, foggy after meals, and craving carbohydrates constantly — insulin resistance is near the top of the differential.
And it can be addressed. Significantly. Without waiting for a diabetes diagnosis.
PracticeRx includes fasting insulin, HOMA-IR, and advanced metabolic markers in our standard biomarker panel. We treat insulin resistance upstream — before it becomes a formal diagnosis.